Effect of berberine on cardiac hypertrophy induced by isoproterenol in rats;

Hypoadiponectinemia——independent risk factor of hypertensive cardiac hypertrophy;

Inhibitory effects of L-arginine-nitric oxide pathway on formation of pathological cardiac hypertrophy and the related mechanisms;

Prescription bolting of total timosaponins with total astragalus saponins on myocardial hypertrophy and initial pharmacodynamic study of total timosaponins and total astragalus saponins complex;

Effects of Benazapril and Propranolo on the mice of hypertensive myocardial hypertrophy;

Protection of daidzein on myocardial hypertrophy and fibrosis in rats;

Protective effects of astragaloside Ⅳ on isoproterenol-induced cardiac hypertrophy in mice;

Transition from Hypertrophy to Heart Failure in Rats with Pressure-Overload;

Serum TNF-α,IL-1β and IL-6 changes through the whole process of over-loaded heart hypertrophy;

Effects of L-tetrahydropalmatine on extracellular matrix proliferation of rats in hypertrophic myocardium caused by pressure overload;

Expression of BMAL1 protein in hypertrophic myocardium of hypertensive rats;

Effects of low dose hydrochlorothiazide on left ventricular hypertrophy induced by pressure-overload in rat;

Effect of Telmisartan on left ventricular hypertrophy and earlier period renal dysfunction in patients with essential hypertension;

PartⅠChanges of Electrophysiological Characteristics in Hypertrophied Myocardium Background: Left ventricular hypertrophy is associated with a greater prevalence of ventricular arrhythmias.